參考文獻 |
Abrahamsen. H., et al., TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J. Immunol., 2004. 173(8):4847-58.
Ariga, M., et al., Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. J. Immunol., 2004. 173(12):7531-8.
Arp, J., et al., Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation. Mol. Cell Biol., 2003. 23(22):8042-57.
Barnes, P.J., Drugs for asthma. Br. J. Pharmacol., 2006. 147 Suppl 1:S297-303.
Baroja, M.L., et al., Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation. J. Immunol., 1999. 162(4):2016-23.
Bender, A.T. and Beavo, J.A., Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev., 2006. 58(3):488-520.
Bjørgo, E. and Taskén. K., Role of cAMP phosphodiesterase 4 in regulation of T-cell function. Crit. Rev. Immunol., 2006. 26(5):443-51.
Borger, P., et al., Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood. 1996. 87(2):691-8.
Chung, K.F., Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol., 2006. 533(1-3):110–117.
Cohn, L., Elias, J.A. and Chupp, G.L., Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol., 2004. 22:789-815.
Conti, M. and Jin, S.L., The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic. Acid. Res. Mol. Biol., 1999. 63:1-38.
Conti, M., et al., Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem., 2003. 278(8):5493-6.
Daniel, P., et al., Differential expression and fuction of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D. J. Immunol., 2007. 178(8):4820-31.
de Rooji, J., Zwartkruis, F.J., et al., Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature, 1998. 396:474-7.
Dent, G., et al., Inhibitionof eosinophil cyclic nucleotide PDE activity and opsonized zymosan-stimulated respiratory burst by “type IV”-selective PDE inhibitors. Br. J. Pharmacol., 1991. 103:1339-46.
Edelman, G.M., et al., The covalent and three-dimensional structure of concanavalin A. Proc. Natl. Acad. Sci. USA, 1972. 69(9):2580-4.
Erdogan, S. and Houslay, M.D., Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J., 1997. 321(Pt1):165-75.
Essayan, D.M., Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol., 2001. 108:671-80.
Essayan, D.M., et al., Effects of nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors on antigen-induced cytokine gene expression in peripheral blood mononuclear cells. Am. J. Respir. Cell Mol. Biol., 1995. 13:692-702.
Freedman, M.H. and Raff, M.C., Induction of increased calcium uptake in mouse T lymphocytes by concanavalin A and its modulation by cyclic nucleotides. Nature, 1975. 255(5507):378-82.
Galli, S.J., Tsai, M. and Piliponsky, A.M., The development of allergic inflammation. Nature. 2008. 454(7203):445-54.
Gavett, S.H., et al., Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivety and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol., 1994. 10:587-93.
Gelfand, E.W., Pro: mice are a good model of human airway disease. Am. J. Respir. Crit. Care Med., 2002. 166(1):5-6; discussion 7-8.
Giembycz, M.A., et al., Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol., 1996. 118(8):1945-58.
Giembycz, M.A., et al., Inhibition of CD4 and CD8 T-lymphocyte (T-CL) proliferation and cytokine secretion by isoenzyme selective phosphodiesterase (PDE) inhibitors: correlation with intracellular cyclic AMP concentrations. Clin. Exp. Allergy, 1994. 24:995.
Giembycz, M.A., Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors. Curr. Opin. Pharmacol., 2005. 5(3):238-44.
Hansen, G., et al., Absence of muscarinic cholinergic airway resposes in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc. Natl. Acad. Sci. USA, 2000. 97:6751-56.
Hatzelmann, A. and Schudt, C., Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J. Pharmacol. Exp. Ther., 2001. 297(1):267-79.
Henney, C.S., Bourne, H.R. and Lichtenstein L.M., The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol., 1972. 108(6):1526-34.
Holt, P.G., et al., Drug development strategies for asthma: in search of a new paradigm. Nat. Immunol., 2004. 5:698.
Hwang, T.L., et al., Viscolin, a new chalcone form Viscum coloratum, inhibits human nentrophil superoxide anion and elastase release via a cAMP-dependent pathway. Free Radical Biology & Medicine, 2006. 41:1433-41.
Jin, S.L.C. and Conti, M., Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNFα-responses. Proc. Natl. Acad. Sci. USA, 2002. 99:7628-33.
Jin, S.L.C., et al., Specific role of phosphodiesterase PDE4B in lipopolysaccharide-induced signaling in mouse macrophages. J. Immunol., 2005. 175(3):1523-31.
Jin, S.L., Richter, W. and Conti, M., Insights into the physiological functions of PDE4s from knockout mice. In: “Cyclic Nucleotide Phosphodiesterases in Health and Disease”, Beavo, J., Francis, S., and Houslay, M. (eds), CRC Press LLC. 2006.
Jones, N.A., et al., Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Pulm. Pharmacol. Ther., 2007. 20(1):60-8.
Kammer, G.M., The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today, 1988. 9(7-8):222-9.
Kanda, N. and Watanabe, S., Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells. Biochem. Pharmacol., 2001. 62(4):495-507.
Kaupp, U.B. and Seifert, R., Cyclic nucleotide-gated ion channels. Physiol. Rev., 2002. 82:769-824.
Kawasaki, H., et al., A family of cAMP-binding proteins that directly activate Rap1. Science, 1998. 282:2275-79.
Kopf, M., et al., Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature, 1993. 362:245-8.
Lichtenstein, L.M. and Margolis, S., Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science, 1968. 161(844):902-3.
Lipworth, B.J., Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet, 2005. 365(9454):167-175.
Mary, D., et al., Regulation of interleukin 2 synthesis by cAMP in human T cells. J. Immunol., 1987. 139(4):1179-84.
Mehats, C., et al., PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J., 2003. 17:1831-41.
Melmon, K.L., Bourne, H.R., et al., Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J. Clin. Invest., 1974. 53(1):13-21.
Mosmann, T.R. and Coffman, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 1989. 7:145-173.
Mustelin, T. and Tasken, K., Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J., 2003. 371:15-27.
Nakajima, H., and Takatsu, K., Role of Cytokines in Allergic Airway Inflammation. Int. Arch. Allergy Immunol., 2007. 142:265–273.
O'Garra, A. and Arai, N., The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol., 2000. 10(12):542-550.
Openshaw, Peter., et al., Heterogeneity of Intracellular Cytokine Synthesis at the Single-Cell Level in Polarized T Helper I and T Helper 2 Populations. J. Exp. Med., 1995. 182(5):1357-67.
Pala, P., et al., et al., Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods., 2000. 243(1-2):107-24.
Persson, C.G., Con: mice are not a good model of human airway disease. Am. J. Respir. Crit. Care Med., 2002. 166(1):6-7; discussion 8.
Robinson, D. S., et al., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 1992. 326:298-304.
Rousseau, E., et al., Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium. Mol. Cel. Biochem., 1994. 140(2):171-5.
Sallusto, F., et al., Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today., 1998. 19(12):568-74.
Sanz, M.J., Cortijo, J. and Morcillo, E.J., PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacol. Ther., 2005. 106:269-97.
Schebesch. C., et al., Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology. 1997. 92(4):478-86.
Seldon, P.M., et al., Phosphodiesterase IV inhibitors and β-adrenoceptor agonist suppress lipopolysaccharide-induced tumour necrosis factor-α generation by human peripheral blood monocytes. Br. J. Pharmacol., 1994. 112:215.
Seybold, J., et al., Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization. J. Biol. Chem., 1998. 273(32):20575-88.
Shum, B.O., Rolph, M.S. and Sewell, W.A., Mechanisms in allergic airway inflammation - lessons from studies in the mouse. Expert. Rev. Mol. Med., 2008. 10:e15.
Takeda, K., et al., Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am. J. Physiol. Lung Cell Mol. Physiol., 2001. 281:394-402.
Tasken, K. and Aandahl, E.M., Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev., 2004. 84:137-67.
Torgersen, K.M., et al., Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal, 2002. 14(1):1-9.
Torphy, T.J., Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med., 1998. 157:351-70.
Umetsu, D.T. and DeKruyff, R.H., Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med., 1997. 215(1):11-20.
van Hove, C.L., et al., Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice. Int. Arch. Allergy Immunol., 2009. 149(3):195-207.
Vischer, T.L., The differential effect of cyclic AMP on lymphocyte stimulation by T- or B-cell mitogens. Immunology, 1976. 30(5):735-9.
Whitesell, R.R., et al., Mitogen-stimulated glucose transport in thymocytes. Possible role of Ca++ and antagonism by adenosine 3':5'-monophosphate. J. Cell Biol., 1977. 72(2):456-69.
Wills-Karp, M., Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol., 1999. 17: 255-81.
Zimmermann, N., et al., Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy Clin. Immunol., 2003. 111:227-42.
Zosky, G.R. et al., Animal models of asthma. Clin. Exp. Allergy, 2007. 37:937-88.
Zosky, G.R. et al., Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation. Clin. Exp. Allergy, 2008. 38:829-38.
|